LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in OCUL — Ocular Therapeutix, Inc
CIK 932974
BOSTON, MA
Position in OCUL
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$73,650
New position
Shares Held
7,500
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#205
of 257 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $43,678,237 across 12 Biotechnology names. OCUL ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,875 | $41,075,697 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,317 | $1,647,653 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,533 | $461,478 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
500 | $268,475 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,000 | $77,400 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
This page
|
7,500 | $73,650 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
278 | $32,545 | |
| 8 | BNTX |
BioNTech SE
|
190 | $17,679 |
All Filings in OCUL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,650 | 7,500 | Shares | Sole | 2026-07-30 | |
| No filing history on record for this holder in this stock. | ||||||